OLIVIA MILLER: Open Payments
NPI 1023639853 · DILLON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,657 in 56 payments from 13 companies in 2025. Trend: 2023 $997 · 2024 $1,580 · 2025 $5,657
Speaker / faculty: $4,350Food & beverage: $834Travel & lodging: $386Education: $87
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 5 | $4,760 |
| Janssen Biotech, Inc. | 10 | $207 |
| GENZYME CORPORATION | 12 | $146 |
| Regeneron Healthcare Solutions, Inc. | 12 | $145 |
| BeOne Medicines USA, Inc. | 4 | $105 |
| Incyte Corporation | 3 | $62 |
| Organon LLC | 3 | $58 |
| SOBI, INC | 1 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| ABBVIE INC. | 1 | $27 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, BRUKINSA, OPZELURA, Vonjo, SKYRIZI, OTEZLA.
Industry payments across SC — which companies pay providers there.
